1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs. MONALEESA-7: doi.org/10.1056/NEJMoa1903765 Free drug samples are a marketing tool: doi.org/10.2105/AJPH.2007.114249 Back us on Patreon! www.patreon.com/plenarysession

Episode metadata supplied by the publisher feed · Published Jun 27, 2019

Embed this episode

Attribution link and audio player

Ready to play

1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina

0:00 2:20:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 2 hours and 20 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on June 27, 2019.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!